0001209191-20-008882.txt : 20200212
0001209191-20-008882.hdr.sgml : 20200212
20200212172021
ACCESSION NUMBER: 0001209191-20-008882
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20605538
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2020-02-10
4
F
0
13458
240.95
D
54788
D
Common Stock
2020-02-11
4
S
0
922
243.42
D
53866
D
Common Stock
2020-02-11
4
S
0
2102
244.67
D
51764
D
Common Stock
2020-02-11
4
S
0
6232
245.62
D
45532
D
Common Stock
2020-02-11
4
S
0
3783
246.52
D
41749
D
Common Stock
2020-02-11
4
S
0
2499
247.62
D
39250
D
Common Stock
2020-02-11
4
S
0
1344
248.52
D
37906
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $243.42 (range $242.88 to $243.81).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $244.67 (range $243.94 to $244.93).
Open market sales reported on this line occurred at a weighted average price of $245.62 (range $245.12 to $246.11).
Open market sales reported on this line occurred at a weighted average price of $246.52 (range $246.14 to $247.11).
Open market sales reported on this line occurred at a weighted average price of $247.62 (range $247.14 to $248.08).
Open market sales reported on this line occurred at a weighted average price of $248.52 (range $248.23 to $248.93).
/s/ Omar White, Attorney-in-Fact
2020-02-12